The company announced that it plans to quickly proceed with out-licensing negotiations with global pharmaceutical companies if the results of phase 3 clinical trials come out at a similar level to the results of phase 2. In order to continue to pursue technology transfer to global big pharma and at the same time obtain direct approval for new drugs, we are in discussions with a non-profit clinical implementation organization specializing in gbm in the United States. Conversely, license out refers to giving permission to a third party to produce and sell products containing technology or intellectual property rights.
Diane Von Furstenberg Net Worth 2023 Bio, Age, Family &More
Big Pharma said that they usually purchase several drugs out of license and then go through a validation process to select the drug that best suits their portfolio. While China maintains its lead in the pharmaceutical technology export market, out-licensing transactions of Korean pharmaceuticals to large overseas pharmaceutical companies also surged by 180%. Recently concluded technology transfer between Hanmi Pharmaceutical and Yuhan Corporation.
[Daily Farm = Reporter Seokjun Lee] The analysis is that the continuous collaborative relationship with Big Pharma was the basis for the big deals (licensing out/lo) of large domestic pharmaceutical companies.
